• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment.伴有远处和非远处转移的食管癌患者预后模型的构建与评估:为临床诊断和治疗提供参考流程
J Gastrointest Oncol. 2021 Aug;12(4):1241-1254. doi: 10.21037/jgo-21-429.
2
A Nomogram to Predict Distant Metastasis for Patients with Esophageal Cancer.列线图预测食管癌患者远处转移
Oncol Res Treat. 2020;43(1-2):2-9. doi: 10.1159/000503613. Epub 2019 Nov 12.
3
Nomogram for predicting overall survival in colorectal cancer with distant metastasis.预测结直肠癌伴远处转移患者总生存期的列线图
BMC Gastroenterol. 2021 Mar 4;21(1):103. doi: 10.1186/s12876-021-01692-x.
4
Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.基于人群的研究:构建并验证用于预测有远处转移的上皮性卵巢癌患者生存结局的列线图。
BMC Cancer. 2021 May 25;21(1):609. doi: 10.1186/s12885-021-07977-4.
5
Establishment and validation of an individualized nomogram to predict distant metastasis in chondrosarcoma patients: a population-based study.建立并验证用于预测软骨肉瘤患者远处转移的个体化列线图:一项基于人群的研究
Transl Cancer Res. 2022 Feb;11(2):327-338. doi: 10.21037/tcr-21-2212.
6
A clinical model to predict distant metastasis in patients with superficial gastric cancer with negative lymph node metastasis and a survival analysis for patients with metastasis.一种用于预测无淋巴结转移的早期胃癌患者远处转移的临床模型和转移患者的生存分析。
Cancer Med. 2021 Feb;10(3):944-955. doi: 10.1002/cam4.3680. Epub 2020 Dec 22.
7
Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis.发展和外部验证两种列线图,以预测成人肢体局限性软组织肉瘤手术后的总生存和远处转移发生:回顾性分析。
Lancet Oncol. 2016 May;17(5):671-80. doi: 10.1016/S1470-2045(16)00010-3. Epub 2016 Apr 5.
8
Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study.初诊时伴有骨转移的肺癌的发病率、预后因素及列线图:一项基于人群的研究
Transl Lung Cancer Res. 2019 Aug;8(4):367-379. doi: 10.21037/tlcr.2019.08.16.
9
Nomogram for Individualized Prediction and Prognostic Factors for Survival in Patients with Primary Spinal Chordoma: A Population-Based Longitudinal Cohort Study.基于人群的纵向队列研究:原发性脊柱脊索瘤患者个体化预测和生存预后因素的列线图。
World Neurosurg. 2019 Aug;128:e603-e614. doi: 10.1016/j.wneu.2019.04.217. Epub 2019 May 1.
10
Prognosis of radiotherapy in medullary thyroid carcinoma patients without distant metastasis.无远处转移的甲状腺髓样癌患者的放疗预后
Transl Cancer Res. 2021 Nov;10(11):4714-4726. doi: 10.21037/tcr-21-1179.

本文引用的文献

1
Healthcare utilization and total costs of care among patients with advanced metastatic gastric and esophageal cancer.晚期转移性胃和食管腺癌患者的医疗保健利用和总护理费用。
Future Oncol. 2021 Jan;17(3):291-299. doi: 10.2217/fon-2020-0516. Epub 2020 Sep 30.
2
Combination Therapy With S-1, Oxaliplatin and Leucovorin in Patients With Advanced Esophageal Squamous Cell Carcinoma.S-1、奥沙利铂和亚叶酸钙联合治疗晚期食管鳞癌患者。
In Vivo. 2019 Nov-Dec;33(6):2249-2254. doi: 10.21873/invivo.11730.
3
Treatments and outcomes of older patients with esophageal cancer: Comparison with younger patients.老年食管癌患者的治疗与结局:与年轻患者的比较。
Mol Clin Oncol. 2019 Oct;11(4):383-389. doi: 10.3892/mco.2019.1909. Epub 2019 Aug 9.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
Primary Tumor Score Based on Tumor Depth and Length Predicts Prognosis in Esophageal Squamous Cell Carcinoma.基于肿瘤深度和长度的原发肿瘤评分可预测食管鳞状细胞癌的预后。
Anticancer Res. 2018 Sep;38(9):5447-5452. doi: 10.21873/anticanres.12876.
6
Surgical treatment of esophageal cancer in the era of multimodality management.食管癌的多模态治疗时代的外科治疗。
Ann N Y Acad Sci. 2018 Dec;1434(1):192-209. doi: 10.1111/nyas.13677. Epub 2018 May 15.
7
A nomogram incorporating six easily obtained parameters to discriminate intrahepatic cholangiocarcinoma and hepatocellular carcinoma.纳入 6 个易于获得的参数的列线图以鉴别肝内胆管细胞癌和肝细胞癌。
Cancer Med. 2018 Mar;7(3):646-654. doi: 10.1002/cam4.1341. Epub 2018 Feb 23.
8
Patterns of distant organ metastases in esophageal cancer: a population-based study.食管癌远处器官转移模式:一项基于人群的研究。
J Thorac Dis. 2017 Sep;9(9):3023-3030. doi: 10.21037/jtd.2017.08.72.
9
Prognostic significance of lymph node metastasis in esophageal squamous cell carcinoma.食管鳞状细胞癌中淋巴结转移的预后意义
Pathol Res Pract. 2017 Jul;213(7):842-847. doi: 10.1016/j.prp.2017.01.023. Epub 2017 Feb 3.
10
A nomogram based on serum bilirubin and albumin levels predicts survival in gastric cancer patients.基于血清胆红素和白蛋白水平的列线图可预测胃癌患者的生存率。
Oncotarget. 2017 Jun 20;8(25):41305-41318. doi: 10.18632/oncotarget.17181.

伴有远处和非远处转移的食管癌患者预后模型的构建与评估:为临床诊断和治疗提供参考流程

Construction and evaluation of prognostic models for esophageal cancer patients with distant and non-distant metastases: providing a reference process for clinical diagnosis and treatment.

作者信息

Zhang Mingxin, Cui Manli, Zuo Qianqian, Wang Li, Wang Jia, Zhu Lin, Yan Rong, Lu Ning, Yan Honglin, Zhang Lingmin

机构信息

Department of Gastroenterology, The First Affiliated Hospital of Xi'an Medical University, Xi'an, China.

Department of Internal Medicine, The Second Clinical Medical College of Shaanxi University of Chinese Medicine, Xianyang, China.

出版信息

J Gastrointest Oncol. 2021 Aug;12(4):1241-1254. doi: 10.21037/jgo-21-429.

DOI:10.21037/jgo-21-429
PMID:34532084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421894/
Abstract

BACKGROUND

Although the current treatment for esophageal cancer has great technological progress, the 5-year survival rate of patients is not optimistic. About 70% of patients with esophageal cancer are at an advanced stage at first diagnosis. These patients are prone to distant metastasis, and the prognosis is poor. Therefore, understanding the risk factors for distant metastasis in patients with esophageal cancer, combined with the prognosis of the patient, can aid in choosing the optimal diagnosis and treatment plan. Ultimately, it will improve the patient's survival time and quality of life. This research aims to construct a model for the risk assessment of distant metastasis in patients with esophageal cancer and prognostic models for patients with distant and non-distant metastases.

METHODS

The Surveillance Epidemiology and End Results (SEER) database was used to select patients with esophageal cancer from 2010 to 2015. The optimal cutoff point was selected for the age and tumor size variables using X-tile. The nomogram was constructed using R software (The R Foundation for Statistical Computing).

RESULTS

Gender, grade, T stage, N stage, and tumor size were independent risk factors associated with distant metastasis in patients with esophageal cancer. The concordance index (C-index) of the nomogram prediction model for whether the patient will have distant metastasis was 0.609. Age, grade, T stage, N stage, and tumor size were independent risk factors affecting the prognosis without distant metastasis. The C-index of the nomogram prediction model for patients with distant metastases was 0.590. Age and T stage were independent risk factors affecting the prognosis of patients with distant metastases. The C-index of the nomogram prediction model was 0.543. The combination of radiotherapy, chemotherapy, and primary surgery yielded the best overall survival for both patients with distant metastases and patients with non-distant metastases.

CONCLUSIONS

A comprehensive assessment of the risk of distant metastasis in patients with esophageal cancer, combined with prognosis prediction, is necessary to provide patients with a reasonable treatment plan.

摘要

背景

尽管目前食管癌的治疗技术有了很大进步,但患者的5年生存率并不乐观。约70%的食管癌患者在初次诊断时已处于晚期。这些患者容易发生远处转移,预后较差。因此,了解食管癌患者远处转移的危险因素,并结合患者的预后情况,有助于选择最佳的诊断和治疗方案。最终,这将提高患者的生存时间和生活质量。本研究旨在构建食管癌患者远处转移风险评估模型以及远处转移和非远处转移患者的预后模型。

方法

使用监测、流行病学和最终结果(SEER)数据库选取2010年至2015年的食管癌患者。使用X-tile软件为年龄和肿瘤大小变量选择最佳截断点。使用R软件(R统计计算基金会)构建列线图。

结果

性别、分级、T分期、N分期和肿瘤大小是食管癌患者远处转移的独立危险因素。患者是否会发生远处转移的列线图预测模型的一致性指数(C指数)为0.609。年龄、分级、T分期、N分期和肿瘤大小是影响无远处转移患者预后的独立危险因素。远处转移患者列线图预测模型的C指数为0.590。年龄和T分期是影响远处转移患者预后的独立危险因素。列线图预测模型的C指数为0.543。放疗、化疗和原发手术联合应用对远处转移患者和非远处转移患者均产生了最佳的总生存期。

结论

对食管癌患者远处转移风险进行综合评估,并结合预后预测,对于为患者提供合理的治疗方案是必要的。